Navigation Links
NY Medical Center Selects Camtronics for Cardiovascular Image and Information Management

by another Camtronics' product that provides specialized image and information management system for pediatric echocardiography.

Integral to this system is one the industry's leading pediatric reporting applications developed by Camtronics' subsidiary VMI Medical, Inc. Verisis EchoIMS features a broad array of analytical tools specifically designed for assessing, diagnosing and treating ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/14/03


Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Medical College team creates website for tracking flu
3. Medical College receives $1.4M cancer grant
4. Medical technology firm lands $100K federal grant
5. Doyle outlines spending for Medical College, UWM
6. Medical College lands $8.1M grant to detect bird flu, bioterror agents
7. Medical College dedicates $140M research facility
8. Dunn to step down as Medical College dean
9. Medical College team seeks stem cell patent
10. Medical College part of $5M cancer study
11. Medical College secures $9.7M research grant

Post Your Comments:
(Date:11/19/2009)... BLAUVELT, N.Y., Nov. 19 Dr. Mate ...xtract, responds to a press release issued on Nove...ian company for making false and self-serving stat...ces. ,, Dr. Hidvegi stated from his office in ...at research on Avemar does not apply to AveULTRA, ...
(Date:11/19/2009)... NEW YORK, Nov. 19 NeoSt...it has sent the following letter to its shareholde...er 30, 2009, of China Biopharmaceuticals Holdings,...pany based in the People,s Republic of China. The ... Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prima...
(Date:11/19/2009)..., MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRN...Decision Resources find that the leading driver of...urope is broad-spectrum activity against gram-posi...ty of organisms that can cause nosocomial pneumoni...ook primarily for agents that provide appropriate ...
(Date:11/19/2009)... MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeut...atient in a randomized Phase 2B study of AEG35156,...elopment for multiple oncology indications. ,, ...e 2 Study of the X-Linked Inhibitor of Apoptosis (... High-dose Cytarabine and Idarubicin in AML Follow...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
.... (Nasdaq: HGSI ) announced today that its presen...erence will be webcast and may be accessed,at htt.../cgi-bin/prnh/20010612/HGSLOGO ), A member of Hu...resent,an overview of the company on Wednesday, Ja... Eastern Time., Investors interested in listening...
...reatment of multi-drug res...b-X Pharmaceuticals, Inc.,("Rib-X" or the "Company...elopment of novel antibiotics for the treatment of...the enrolment of the first patients in two,separat...te the safety and,efficacy of RX-1741 in the treat...
... THRM ), a leader in non-invasive tissue tightenin...it will present at the 10th Annual Needham &,Compa...rk City. The,Company,s presentation is scheduled f...Time. Stephen J. Fanning, Chairman, President and ... business strategy and,historical financial result...
Other Biology Technology:Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 2Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 3
(Date:11/20/2009)...009) Scientists from the Marine Biogeochemistry a...search Laboratory (NRL) organized and led a team o...c expedition to initiate methane hydrate explorati...ariation of sediment contribution to Arctic climat...r Polar Sea as a research platform, three cross-sh...
(Date:11/20/2009)...coal-tar-based sealcoats in parking lots may be th... a USGS study. PAHs or polycyclic aromatic hydro...d tar deposits, and can have toxic effects. It,s l...dust; however, the specific sources of these PAHs ...ust from indoor areas near parking lots with coal-...
(Date:11/20/2009)... German . , In the current online issue of ...nie Eyerich and Dr. Kilian Eyerich together with t...stituto Dermopatico dell,Immacolata in Rome, prese... milestone on the way to developing new treatment ...riasis and allergic reactions and potentially also...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 1Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 5The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 1The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 2The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 3Vascular Study Group of New England Selects Clinical Data Pathways Powered by M2S as Quality Improvement Registry Provider 59791 1Vascular Study Group of New England Selects Clinical Data Pathways Powered by M2S as Quality Improvement Registry Provider 59791 2Vascular Study Group of New England Selects Clinical Data Pathways Powered by M2S as Quality Improvement Registry Provider 59791 3
... to indicate that the diversity of marine creature...s of years in step with predator-prey encounters, ...ngs of the National Academy of Science. , For dec...sts, biologists, and ecologists on the role of eco...ng term patterns of animal evolution. , John War...
...tant to UNESCO and a former Administrator of the N...AA), will deliver a talk at Stevens Institute of T...e Habitability of Planet Earth: A Time of Reckonin... Center for Technology Management, Room 122, at 3:... the Stevens campus in Hoboken, N.J., near the int...
...harmaceuticals (NASDAQ: ABPI) announces evidence t...S), are due to a fungal-induced inflammation as or...nic. The data were collected as part of the Compa... lead pharmaceutical product, SinuNase, an intrana....01% suspension. In order to be enrolled in the c...
Other Biology News:Study reveals predation-evolution link 2Study reveals predation-evolution link 3Global Warming and the Habitability of Planet Earth, Sept. 26 2SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma 2
Rabbit Anti-Human NIRF Polyclonal Antibody, Unconjugated from Abcam
Acc I from Invitrogen
SexA I from New England Biolabs
Psp1406 I from Takara Mirus Bio
Biology Products: